Novo Nordisk's GLP-1s: Bridging Medical and Lifestyle Drug Categories
Novo Nordisk blurs the line between medications and lifestyle enhancements with its GLP-1s, sparking debate over their t...
Found 513 results
Novo Nordisk blurs the line between medications and lifestyle enhancements with its GLP-1s, sparking debate over their t...
GLP-1 drugs are now being marketed for general wellness rather than just obesity, while Merck and Daiichi face setbacks...
The FDA has approved AbbVie's new oral medication for Parkinson's disease, marking a significant advancement in treatmen...
The outlook for employer-sponsored health insurance is grim, with experts predicting even higher costs in 2027, as recen...
Merck's recent decision to discontinue Recarbrio raises questions about the pharmaceutical industry's commitment to tack...
Research highlights the long-term respiratory risks posed by toxic metals from the 2023 Maui wildfires, persisting even...
Radiology is evolving as practices actively adopt AI technologies to enhance services and attract talent, moving beyond...
Heidi Overton's ascent from a small New Mexico town to FDA commissioner nominee reflects her commitment to public health...
Gilead Sciences is ramping up its commitment to inflammation and immunology, crucial for its future growth alongside vir...
The U.S. faces its most significant measles outbreak in over three decades, with unvaccinated individuals suffering the...
Insurers are opposing Medicare's new proposal that alters how remote patient monitoring services are delivered, raising...
Heidi Overton's Senate hearing as FDA commissioner nominee underscores urgency in drug approvals, while states weigh Med...
Kyverna's recent study shows promising, enduring autoimmune relief from its cell therapy, signaling a significant advanc...
An Indonesian court's decision against patent evergreening signals a shift towards improved medicine access, resonating...
Explore the implications of rising Chinese biotech development and the potential impact of FDA nominee Heidi Overton on...
Pregnant and lactating individuals face barriers in finding relevant clinical trials due to a lack of structured data on...
Addiction clinics report a sharp rise in patients seeking help for kratom and 7-OH dependence amid growing warnings abou...
This article reflects on personal health struggles and the frustrations with today's medical system, highlighting a broa...
Zach Lahn, GOP candidate for Iowa governor, is leveraging RFK Jr.'s support amidst a challenging race against a Democrat...
The FDA's approval of daraxonrasib provides new hope for pancreatic cancer patients, targeting the challenging KRAS muta...